Cargando…

Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors

BACKGROUND: As the most lethal gynecologic cancer, ovarian cancer (OV) holds the potential of being immunotherapy-responsive. However, only modest therapeutic effects have been achieved by immunotherapies such as immune checkpoint blockade. This study aims to propose a generalized stroma-immune prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Dong, Duan, Mei-Han, Yuan, Qiu-Er, Li, Zhi-Ling, Luo, Chuang-Hua, Cui, Lan-Yue, Li, Li-Chao, Xiao, Ying, Zhu, Xian-Ying, Zhang, Hai-Liang, Feng, Gong-Kan, Liu, Guo-Chen, Deng, Rong, Li, Jun-Dong, Zhu, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472577/ https://www.ncbi.nlm.nih.gov/pubmed/37658364 http://dx.doi.org/10.1186/s12967-023-04422-x

Ejemplares similares

Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer
por: Yang, Dong, et al.
Publicado: (2023)

A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation
por: Mega, Alessandro, et al.
Publicado: (2023)

Recurrent PDGFRB mutations in unicentric Castleman disease
por: Li, Zhaoming, et al.
Publicado: (2019)

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer
por: Cai, Du, et al.
Publicado: (2023)

Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes
por: Chang, Hung, et al.
Publicado: (2012)

Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review
por: Wang, Zhe, et al.
Publicado: (2022)

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
por: Strell, Carina, et al.
Publicado: (2021)

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
por: Zheng, Jia-Hao, et al.
Publicado: (2022)

SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB
por: Song, Guiqin, et al.
Publicado: (2017)

MicroRNA-518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB
por: Xu, Xiaolong, et al.
Publicado: (2017)

Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient
por: Negri, T, et al.
Publicado: (2007)

Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
por: Di Giacomo, Danika, et al.
Publicado: (2021)

Corneal Vascularization Associated With a Novel PDGFRB Variant
por: Gladkauskas, Titas, et al.
Publicado: (2023)

Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer
por: Chen, Ying, et al.
Publicado: (2015)

Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t(5;10)(q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene
por: Yamazaki, Miki, et al.
Publicado: (2019)

The Role of the Tumor Stroma in Ovarian Cancer
por: Davidson, Ben, et al.
Publicado: (2014)

Identification of Transcriptional Signatures of Colon Tumor Stroma by a Meta-Analysis
por: Uddin, Md. Nazim, et al.
Publicado: (2019)

Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer
por: Zhao, Meng-Dan, et al.
Publicado: (2019)

Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
por: Wallmann, Tatjana, et al.
Publicado: (2018)

Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib
por: Hassan, Mohammed, et al.
Publicado: (2019)

Corneal Stroma Regeneration with Acellular Corneal Stroma Sheets and Keratocytes in a Rabbit Model
por: Ma, Xiao Yun, et al.
Publicado: (2015)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
por: Zhang, Xuehong, et al.
Publicado: (2023)

Functional Characterization of Germline Mutations in PDGFB and PDGFRB in Primary Familial Brain Calcification
por: Vanlandewijck, Michael, et al.
Publicado: (2015)

Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling
por: Arts, Florence A, et al.
Publicado: (2015)

Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis
por: Welsh, Seth J., et al.
Publicado: (2017)

Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
por: Furtado, Vanessa Fiorini, et al.
Publicado: (2018)

Temperature-dependent autoactivation associated with clinical variability of PDGFRB Asn666 substitutions
por: Bredrup, Cecilie, et al.
Publicado: (2021)

TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway
por: Sun, Tianshui, et al.
Publicado: (2021)

The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer
por: Li, Jiajia, et al.
Publicado: (2022)

A Preliminary Study on the Characteristics of microRNAs in Ovarian Stroma and Follicles of Chuanzhong Black Goat during Estrus
por: Lu, Tingting, et al.
Publicado: (2020)

Activating mutation of PDGFRB gene in a rare cardiac undifferentiated intimal sarcoma of the left atrium: a case report
por: Fu, Xiaoling, et al.
Publicado: (2017)

Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
por: Karkampouna, Sofia, et al.
Publicado: (2020)

A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
por: Xu, Xuyao, et al.
Publicado: (2023)

Ovarian Cancer Stroma: Pathophysiology and the Roles in Cancer Development
por: Furuya, Mitsuko
Publicado: (2012)

CNS tumor stroma transcriptomics identify perivascular fibroblasts as predictors of immunotherapy resistance in glioblastoma patients
por: Zarodniuk, Maksym, et al.
Publicado: (2023)

Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy
por: Qu, Shiqiang, et al.
Publicado: (2023)

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma
por: Yang, Chuang, et al.
Publicado: (2023)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
por: Huang, Xu, et al.
Publicado: (2023)

Pdgfrb‐Cre targets lymphatic endothelial cells of both venous and non‐venous origins
por: Ulvmar, Maria H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_50bbllted44s23rho60f3f7ag8